Tilray Brands, Inc. short interest in 2023
In 2023, Tilray Brands, Inc.'s disclosed short interest ran from 8.34% of shares outstanding on 31 Mar 2023 to 15.67% on 29 Dec 2023, a change of +7.33 percentage points. The year's high was 17.15% on 15 Dec 2023 and its low 7.95% on 14 Apr 2023, averaging 12.95% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.64 days on 30 Nov 2023. Full history: Tilray Brands, Inc..
Cite this page
By year: 2021 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 8.34% (31 Mar 2023)
- End of year
- 15.67% (29 Dec 2023)
- Change
- +7.33 pp
- High
- 17.15% (15 Dec 2023)
- Low
- 7.95% (14 Apr 2023)
- Average
- 12.95%
- Highest days to cover
- 13.64 (30 Nov 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2023 | 8.34% | 4.58 | 10-Q filed, results (8-K) |
| 14 Apr 2023 | 7.95% | 4.07 | 10-Q filed, results (8-K) |
| 28 Apr 2023 | 8.23% | 5.35 | |
| 15 May 2023 | 8.01% | 4.30 | |
| 31 May 2023 | 10.80% | 4.21 | |
| 15 Jun 2023 | 12.28% | 3.95 | |
| 30 Jun 2023 | 11.93% | 5.19 | |
| 14 Jul 2023 | 12.45% | 3.69 | |
| 31 Jul 2023 | 11.93% | 2.84 | 10-K filed, results (8-K) |
| 15 Aug 2023 | 13.52% | 2.62 | |
| 31 Aug 2023 | 12.67% | 3.13 | |
| 15 Sep 2023 | 14.98% | 2.06 | |
| 29 Sep 2023 | 16.40% | 4.46 | |
| 13 Oct 2023 | 15.29% | 5.80 | 10-Q filed, results (8-K) |
| 31 Oct 2023 | 15.33% | 9.28 | |
| 15 Nov 2023 | 16.45% | 10.61 | |
| 30 Nov 2023 | 16.72% | 13.64 | |
| 15 Dec 2023 | 17.15% | 6.54 | |
| 29 Dec 2023 | 15.67% | 3.86 |
See also: Tilray Brands, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.